The International Finance Corporation (IFC) has disclosed a proposed investment in AK Life Sciences Limited (AKL), a pharmaceutical manufacturer and distributor headquartered in Uganda, and with operations in Uganda, Tanzania, Rwanda, Burundi and Kenya operating under the brand name ‘Abacus Pharma’.

The proposed IFC investment is an ‘A’ loan of up to $12.5 million. The ...